Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
Journal of Personalized Medicine · 23.02.2023 · 13 (3) · 389
DOI: 10.3390/jpm13030389 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 23.02.2023. Verfasst von Md Abdus Subhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, ShahJalal University of Science and Technology, Sylhet 3114, Bangladesh. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The innovative development of nanomedicine has promised effective treatment options compared to the standard therapeutics for cancer therapy. However, the efficiency of EPR-targeted nanodrugs is not always pleasing as it is strongly prejudiced by the heterogeneity of the enhanced permeability and retention effect (EPR). Targeting the dynamics of the EPR effect and improvement of the therapeutic effects of nanotherapeutics by using EPR enhancers is a vital approach to developing cancer therapy. Inadequate data on the efficacy of EPR in humans hampers the clinical translation of cancer drugs. Molecular targeting, physical amendment, or physiological renovation of the tumor microenvironment (TME) are crucial approaches for improving the EPR effect. Advanced imaging technologies for the visualization of EPR-induced nanomedicine distribution in tumors, and the use of better animal models, are necessary to enhance the EPR effect. This review discusses strategies to enhance EPR effect-based drug delivery approaches for cancer therapy and imaging technologies for the diagnosis of EPR effects. The effort of studying the EPR effect is beneficial, as some of the advanced nanomedicine-based EPR-enhancing approaches are currently undergoing clinical trials, which may be helpful to improve EPR-induced drug delivery and translation to clinics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, ShahJalal University of Science and Technology, Sylhet 3114, Bangladesh.
- CPBN, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
- Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab 63100, Pakistan.
- Department of Pharmacy Services, DHQ Hospital Jhang 35200, Primary and Secondary Healthcare Department, Government of Punjab, Lahore, Punjab 54000, Pakistan.
- Department of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.
ORCID-Profile: Md Abdus Subhan, Farzana Parveen, Nina Filipczak, Satya Siva Kishan Yalamarty
Zitieren
APA
Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023). Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of Personalized Medicine, 13(3), 389. https://doi.org/10.3390/jpm13030389
Vancouver
Subhan MA, Parveen F, Filipczak N, Yalamarty SSK, Torchilin VP. Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of Personalized Medicine. 2023;13(3):389. doi:10.3390/jpm13030389
BibTeX
@article{Subhan2023,
author = {Subhan, Md Abdus and Parveen, Farzana and Filipczak, Nina and Yalamarty, Satya Siva Kishan and Torchilin, Vladimir P},
title = {Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {3},
pages = {389},
doi = {10.3390/jpm13030389}
}
EUVIMED